外血管植入式心脏转换器-除器:技术,证据和临床前景
Eleonora Angelini1, Karolin Albert1, David Duncker2
1Hannover Herzrhythmus Centrum, Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Herz
|October 16, 2025
概括
血管外 implantable cardioverter-defibrillator (EV-ICD) 提供了一个安全的替代传统的ICD,减少血管内风险. 早期数据显示,在选定的患者中,高成功率和有效的心律失常管理.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 静脉输入植入式心脏转换器-除器 (ICD) 携带血管内并发症的风险.
- 外血管植入式心脏转换器-除器 (EV-ICD) 系统提供了一个完全外血管的替代方案.
- EV-ICD的目的是减轻血管内问题,同时保持设备的性能.
研究的目的:
- 评估EV-ICD系统的安全性和有效性.
- 评估程序成功率和并发症概况.
- 分析EV-ICDs的现实性能和患者选择标准.
主要方法:
- 对EV-ICD植入的程序经验和早期现实世界数据的审查.
- 对设备功能的分析,包括除,抗心动节奏和心管理.
- 评估并发症的发生率,心律失常的终止,以及减少不适当的治疗.
主要成果:
- 植入成功率高,主要并发症发生率低.
- 有效地终止腹性心力衰竭与抗心力衰竭节奏.
- 由于优化了的放置和算法,减少了不合适的疗法;探测是可行的.
结论:
- EV-ICD是为选定的患者提供安全有效的选择,包括年轻人或血管通道有限的患者.
- 患者的选择至关重要,不包括那些需要永久节拍或有解剖学/放射治疗限制的患者.
- 需要进行进一步的长期研究,以确定EV-ICD在预防心脏突发死亡方面的确切作用.
相关概念视频
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Cardiomyopathy II: Dilated Cardiomyopathy
464
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464
Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Cardiopulmonary Resuscitation III: AED Use
526
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
526
Dysrhythmias VI: Management of Dysrhythmias
428
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
428


